Vaccines
From the Journals
Big drop in U.S. cervical cancer rates, mortality in younger women
This analysis lines up with previous evidence from U.S. epidemiologic data.
Latest News
Pfizer COVID vaccine is 100% effective in adolescents: Study
The clinical trial researchers found no serious safety concerns while following patients for 6 months.
Latest News
Surveillance for measles is a victim of the COVID pandemic
Having a “cohort of children who have missed measles vaccine creates the reservoir of susceptibility that will provide the nidus for the next big...
Latest News
30% of docs say they don’t want own kids 5-11 to get COVID vaccine
All of the unvaccinated physicians who responded to the poll said they had no confidence in the vaccine for kids.
Latest News
Schools, pediatricians look to make up lost ground on non–COVID-19 vaccinations
Despite a rebound, immunization rates are still lower than in 2019, and disparities in rates between racial and economic groups, particularly for...
News from the FDA/CDC
CDC: All adults should be eligible for Pfizer, Moderna boosters
More than 70 million adults are now eligible for booster shots in the United States, but only about 31 million people have received one.
News
FDA authorizes COVID boosters for all U.S. adults
The CDC’s Advisory Committee on Immunization Practices will meet on Nov. 19 to review the science supporting a more widespread need for booster...
Conference Coverage
mRNA COVID vaccine response found mostly robust in RA, SLE patients
A trial found that immunosuppressed adults with autoimmune disease had a robust antibody response to the mRNA vaccine with no excess adverse...
Latest News
Pfizer seeks EUA expansion for COVID-19 booster
Pfizer is submitting a study of booster effects on 10,000 people to make its case.
Latest News
COVID vaccines’ protection dropped sharply over 6 months: Study
“Although vaccination remains protective against SARS-CoV-2 infection, protection waned as the Delta variant emerged in the U.S.”
Feature
ACIP recommends HBV vaccination for all adults under 60
“The past decade has illustrated that risk-based screening has got us as far as it can take us.”